Hiroo Ueno1, 6, Mao Sakita-Ishikawa1, Yoshihiro Morikawa2, Toru Nakano3, Toshio Kitamura4
& Masaki Saito1, 51
Virology Division, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
2
Department of Anatomy and Neurobiology, Wakayama Medical School, Kimiidera, Wakayama 641-8509, Japan.
3
Department of Molecular Cell Biology, Research Institute for Microbial Diseases, Osaka University, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan.
4
Division of Cellular Therapy, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.
5
Department of Oncology and Pharmacodynamics, Meiji Pharmaceutical University, 2-522-1 Noshio, Kiyose-shi, Tokyo 204-8588, Japan.
6
Present address: Department of Pathology and Developmental Biology, Stanford University School of Medicine, Stanford, CA 94305.
Correspondence should be addressed to Hiroo Ueno hirueno@gan2.res.ncc.go.jp
